Remove Antibody Remove Clinical Research Remove Drug Delivery Systems Remove Marketing
article thumbnail

Exosomes: A Deeper Look into Service Providers Market

Roots Analysis

Presently, outsourcing of exosome related services has become a popular practice where drug developers are actively outsourcing their operations to specialized repurposed-based service providers, which are known to have the required capabilities and expertise. Exosome Service Providers – Current Market Landscape. Web: [link].

article thumbnail

Next Generation Complement Therapeutics: Potential Life-Changing Therapies for Multiple Rare Disorders

Roots Analysis

Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention. Next Generation Complement Therapeutics – Current Market Landscape. The market is characterized by a mix of well-established and small firms. Next Generation Complement Therapeutics Market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Metabolomics: An Emerging yet Powerful Tool in Clinical Research and Development

Roots Analysis

Therefore, unknown metabolite identification has a significant impact on omics research and biomarker discovery. Metabolomics Services– Current Market Landscape. Considering the aforementioned factors, we are led to believe that the metabolomics services market is likely to witness rapid growth over the next few years.

article thumbnail

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. In a recent webinar, Dr. Vornov described the history and current progress in targeted CNS therapeutic delivery.

Trials 83